Using MKK4's metastasis suppressor function to identify and dissect cancer cell-microenvironment interactions during metastatic colonization

Cancer and Metastasis Reviews

Volumn 31, Issue 3-4, 2012, Pages 605-613

  Krishnan, Venkatesh ^a   Stadick, Nathan ^a   Clark, Robert ^a   Bainer, Russell ^a   Veneris, Jennifer T ^b   Khan, Shaheena ^a,d   Drew, Angela ^c   Rinker Schaeffer, Carrie ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

^d RUSH MEDICAL COLLEGE   (United States)

Author keywords

Cancer evolution; Metastasis suppressors; Microenvironment; Milky spots; MKK4; Omentum; Parallel progression model

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; ENZYME ACTIVATION; HUMAN; METASTASIS; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

ANIMALS; FEMALE; HUMANS; MAP KINASE KINASE 4; NEOPLASM METASTASIS; OVARIAN NEOPLASMS; TUMOR MICROENVIRONMENT; TUMOR SUPPRESSOR PROTEINS;

EID: 84867980423     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/s10555-012-9371-y     Document Type: Article

References (42)

1. Lin, H.; Balic, M.; Zheng, S.; Datar, R.; & Cote, R. J. (2011). Disseminated and circulating tumor cells: role in effective cancer management. Critical Reviews in Oncology/Hematology, 77(1), 1-11.
2. McGowan, P. M.; Kirstein, J. M.; & Chambers, A. F. (2009). Micrometastatic disease and metastatic outgrowth: clinical issues and experimental approaches. Future Oncology, 5(7), 1083-1098.
3. Sosa, M. S.; Avivar-Valderas, A.; Bragado, P.; Wen, H. C.; & Aguirre-Ghiso, J. A. (2011). ERK1/2 and p38α/β signaling in tumor cell quiescence: opportunities to control dormant residual disease. Clinical Cancer Research, 17(18), 5850-5857.
4. Taylor, J.; Hickson, J.; Lotan, T.; Yamada, D. S.; & Rinker-Schaeffer, C. (2008). Using metastasis suppressor proteins to dissect interactions among cancer cells and their microenvironment. Cancer and Metastasis Reviews, 27(1), 67-73.
5. Wikman, H.; Vessella, R.; & Pantel, K. (2008). Cancer micrometastasis and tumour dormancy. Apmis, 116(7-8), 754-770.
6. Klein, C. A. (2009). Parallel progression of primary tumours and metastases. Nature Reviews Cancer, 9(4), 302-312.
7. Gatenby, R. A.; & Gillies, R. J. (2008). A microenvironmental model of carcinogenesis. Nature Reviews Cancer, 8(1), 56-61.
8. Chung, L. W. K.; Huang, W. C.; Sung, S. Y.; Wu, D.; Odero-Marah, V.; Nomura, T.; et al. (2006). Stromal-epithelial interaction in prostate cancer progression. Clinical Genitourinary Cancer, 5(2), 162-170.
9. Cunha, G. R.; & Ricke, W. A. (2011). A historical perspective on the role of stroma in the pathogenesis of benign prostatic hyperplasia. Differentiation, 82, 168-172.
10. Kenny, P. A.; & Bissell, M. J. (2003). Tumor reversion: correction of malignant behavior by microenvironmental cues. International Journal of Cancer, 107(5), 688-695.
11. Kaplan, R. N.; Rafii, S.; & Lyden, D. (2006). Preparing the soil: the premetastatic niche. Cancer Research, 66(23), 11089-11093.
12. Peinado, H.; Lavothskin, S.; & Lyden, D. (2011). The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts. Seminars in Cancer Biology, 21(2), 139-146.
13. Gerber, S. A.; Rybalko, V. Y.; Bigelow, C. E.; Lugade, A. A.; Foster, T. H.; Frelinger, J. G.; et al. (2006). Preferential attachment of peritoneal tumor metastases to omental immune aggregates and possible role of a unique vascular microenvironment in metastatic survival and growth. The American Journal of Pathology, 169(5), 1739.
14. Khan, S. M.; Funk, H. M.; Thiolloy, S.; Lotan, T. L.; Hickson, J.; Prins, G. S.; et al. (2010). In vitro metastatic colonization of human ovarian cancer cells to the omentum. Clinical and Experimental Metastasis, 27(3), 185-196.
15. Wilkosz, S.; Ireland, G.; Khwaja, N.; Walker, M.; Butt, R.; de Giorgio-Miller, A.; et al. (2005). A comparative study of the structure of human and murine greater omentum. Anatomy and Embryology, 209(3), 251-261.
16. Hickson, J. A.; Huo, D.; Vander Griend, D. J.; Lin, A.; Rinker-Schaeffer, C. W.; & Yamada, S. D. (2006). The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma. Cancer Research, 66(4), 2264.
17. Yamada, S. D.; Hickson, J. A.; Hrobowski, Y.; Vander Griend, D. J.; Benson, D.; Montag, A.; et al. (2002). Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma. Cancer Research, 62(22), 6717.
18. Khan, S. M.; Taylor, J. L.; & Rinker-Schaeffer, C. W. (2010). Disrupting ovarian cancer metastatic colonization: insights from metastasis suppressor studies. Journal of Oncology, 2010, 286925.
19. Bainer, R. O.; Taylor, J. V.; Yamada, D. S.; Montag, A.; Lingen, M. W.; Gilad, Y.; et al. (2012). Time-dependent transcriptional profiling links gene expression to mitogen-activated protein kinase kinase 4 (MKK4)-mediated suppression of omental metastatic colonization. Clinical and Experimental Metastasis, 29, 397-408.
20. Taylor, J. L.; Szmulewitz, R. Z.; Lotan, T.; Hickson, J.; Griend, D. V.; Yamada, S. D.; et al. (2008). New paradigms for the function of JNKK1/MKK4 in controlling growth of disseminated cancer cells. Cancer Letters, 272(1), 12-22.
21. Lancaster, J.; Dressman, H.; Clarke, J.; Sayer, R.; Martino, M.; Cragun, J.; et al. (2006). Identification of genes associated with ovarian cancer metastasis using microarray expression analysis. International Journal of Gynecological Cancer, 16(5), 1733-1745.
22. Lotan, T.; Hickson, J.; Souris, J.; Huo, D.; Taylor, J.; Li, T.; et al. (2008). c-Jun NH2-terminal kinase activating kinase 1/mitogen-activated protein kinase kinase 4-mediated inhibition of SKOV3ip. 1 ovarian cancer metastasis involves growth arrest and p21 up-regulation. Cancer Research, 68(7), 2166.
23. Collins, D.; Hogan, A. M.; O'Shea, D.; & Winter, D. C. (2009). The omentum: anatomical, metabolic, and surgical aspects. Journal of Gastrointestinal Surgery, 13(6), 1138-1146.
24. Morison, R. (1906). Remarks on some functions of the omentum. British Medical Journal, 1(2350), 76.
25. Platell, C.; Cooper, D.; Papadimitriou, J. M.; & Hall, J. C. (2000). The omentum. World Journal of Gastroenterology, 6(2), 169-176.
26. Dux, K. (1990). Anatomy of the greater and lesser omentum in the mouse with some physiological implications. In H. S. Goldsmith (Ed.), The omentum: research and clinical applications (pp. 19-43). New York: Springer.
27. Michailova, K. N.; & Usunoff, K. G. (2004). The milky spots of the peritoneum and pleura: structure, development and pathology. Biomedical Reviews, 15, 47-66.
28. Williams, R. (1990). Angiogenesis and the greater omentum. In H. S. Goldsmith (Ed.), The omentum: research and clinical applications (pp. 45-61). New York: Springer.
29. Mironov, V.; Gusev, S.; & Baradi, A. (1979). Mesothelial stomata overlying omental milky spots: scanning electron microscopic study. Cell and tissue research, 201(2), 327-330.
30. Simer, P. H. (1934). On the morphology of the omentum, with especial reference to its lymphatics. American Journal of Anatomy, 54(2), 203-228.
31. Nieman, K. M.; Kenny, H. A.; Penicka, C. V.; Ladanyi, A.; Buell-Gutbrod, R.; Zillhardt, M. R.; et al. (2011). Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nature Medicine, 17(11), 1498-1503.
32. Cai, J.; Tang, H.; Xu, L.; Wang, X.; Yang, C.; Ruan, S.; et al. (2011). Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness. Carcinogenesis, 33(1), 20-29.
33. Gerber, S. A.; Rybalko, V. Y.; Bigelow, C. E.; Lugade, A. A.; Foster, T. H.; Frelinger, J. G.; et al. (2006). Preferential attachment of peritoneal tumor metastases to omental immune aggregates and possible role of a unique vascular microenvironment in metastatic survival and growth. [Research Support, N.I.H.; Extramural]. The American Journal of Pathology, 169(5), 1739-1752. doi: 10.2353/ajpath.2006.051222.
34. Sorensen, E. W.; Gerber, S. A.; Sedlacek, A. L.; Rybalko, V. Y.; Chan, W. M.; Lord, E. M.; et al. (2009). Omental immune aggregates and tumor metastasis within the peritoneal cavity. Immunologic research, 45(2), 185-194.
35. Szmulewitz, R. Z.; Clark, R.; Lotan, T.; Otto, K.; Taylor Veneris, J.; Macleod, K.; et al. (2011). MKK4 suppresses metastatic colonization by multiple highly metastatic prostate cancer cell lines through a transient impairment in cell cycle progression. International Journal of Cancer, 130, 509-520.
36. Vander Griend, D. J.; Kocherginsky, M.; Hickson, J. A.; Stadler, W. M.; Lin, A.; & Rinker-Schaeffer, C. W. (2005). Suppression of metastatic colonization by the context-dependent activation of the c-Jun NH2-terminal kinase kinases JNKK1/MKK4 and MKK7. Cancer Research, 65(23), 10984.
37. Thiolloy, S.; & Rinker-Schaeffer, C. W. (2011). Thinking outside the box: using metastasis suppressors as molecular tools. Seminars in Cancer Biology, 21(2), 89-98. doi: 10.1016/j.semcancer.2010.12.008.
38. Gatenby, R. A.; Gillies, R. J.; & Brown, J. S. (2011). Of cancer and cave fish. Nature Reviews Cancer, 11(4), 237-238.
39. Laland, K. N.; Day, R. L.; & Odling-Smee, F. J. (2003). Rethinking adaptation: the niche-construction perspective. Perspectives in Biology and Medicine, 46(1), 80-95.
40. Bissell, M.; & Barcellos-Hoff, M. (1987). The influence of extracellular matrix on gene expression: is structure the message? Journal of Cell Science, 8(Supplement), 327.
41. Xu, R.; Boudreau, A.; & Bissell, M. J. (2009). Tissue architecture and function: dynamic reciprocity via extra- and intra-cellular matrices. Cancer and Metastasis Reviews, 28(1), 167-176.
42. Knopeke, M. T.; Ritschdorff, E. T.; Clark, R.; Vander Griend, D. J.; Khan, S.; Thobe, M.; et al. (2011). Building on the foundation of daring hypotheses: Using the MKK4 metastasis suppressor to develop models of dormancy and metastatic colonization. FEBS Letters, 585, 3159-3165.